DoD Awards Fox Chase Researcher $673K to Develop Lung Cancer Test

Aug 21, 2018

|

The story has been modified to include information on a separate grant awarded to Creatv MicroTech for research on which Fox Chase is collaborating.

NEW YORK (360Dx) – Fox Chase Cancer Center announced on Monday that Martin Edelman has received a $673,000 award from the US Department of Defense to develop a test for the early detection of early-stage lung cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

DoD Awards Fox Chase Researcher $673K to Develop Lung Cancer Test

To read the full story....

Breaking News

Beckman Coulter Gets FDA Emergency Use Authorization for COVID-19 Inflammatory Response Immunoassay

DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development

CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto

AnPac Bio-Medical Nabs $7M Equity Investment for Cancer Early Detection Platform

Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology

Featured White Papers

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

What's Popular?

Johns Hopkins-Led Team Launches Startup to Tackle Breast Cancer, Glioblastoma Applications

Owlstone Medical, Addenbrooke's Hospital See Promise in Breath Dx Test for Staging Liver Disease

Biocartis Receives €1.2M Flemish Government Grant to Develop GeneFusion Assay on Idylla Platform

Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Sponsorships